XTNT
Xtant Medical Holdings, Inc.Company Information
- Company Name
- Xtant Medical Holdings, Inc.
- CIK
- CIK0001453593
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- XTNT: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- XTNT
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-11-17
- Last sale
- 2025-04-10
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 73,114,592
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 80,052,489
- Shares outstanding
- 140,258,667
- Ownership
- 57.07%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- 18.75%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 10 | 12 | 17 | 10 | 7 | 5 | 6 | 7 | 5 | 5 | 6 | 9 | ||||||
| Restricted Cash Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 19 | 17 | 18 | 26 | 27 | 23 | 21 | 21 | 21 | 21 | 21 | 19 | ||||||
| Inventory Net | 33 | 32 | 30 | 41 | 40 | 39 | 39 | 42 | 41 | 39 | 37 | 34 | ||||||
| Notes And Loans Receivable Net Current | - | - | 10 | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 2 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | ||||||
| Assets Current | 65 | 63 | 78 | 78 | 76 | 69 | 67 | 71 | 69 | 67 | 65 | 64 | ||||||
| Property Plant And Equipment Net | 6 | 6 | 6 | 10 | 10 | 11 | 10 | 10 | 9 | 9 | 9 | 9 | ||||||
| Operating Lease Right Of Use Asset | 3 | 3 | 3 | 4 | 3 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Goodwill | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 10 | 10 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 80 | 78 | 94 | 106 | 103 | 96 | 94 | 99 | 96 | 94 | 93 | 92 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 6 | 5 | 4 | 7 | 7 | 7 | 8 | 8 | 7 | 7 | 7 | 5 | ||||||
| Accrued Liabilities Current | 7 | 8 | 11 | 12 | 11 | 10 | 8 | 9 | 9 | 10 | 10 | 9 | ||||||
| Long Term Debt Current | 4 | 4 | 4 | - | - | - | - | 3 | - | - | - | 3 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Lines Of Credit Current | 12 | 0 | 11 | 11 | 12 | 11 | 12 | 13 | 12 | 10 | 5 | 4 | ||||||
| Liabilities Current | 30 | 19 | 29 | 36 | 31 | 30 | 29 | 34 | 28 | 28 | 23 | 22 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 2 | 3 | 3 | 3 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Finance Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Debt Noncurrent | 7 | 8 | 11 | 17 | 22 | 22 | 22 | 19 | 22 | 17 | 17 | 14 | ||||||
| Other Liabilities | - | - | - | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Other Liabilities Noncurrent | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | - | - | ||||||
| Liabilities | 40 | 29 | 43 | 56 | 55 | 52 | 51 | 53 | 51 | 46 | 41 | 37 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 307 | 306 | 305 | 305 | 304 | 303 | 303 | 302 | 296 | 295 | 294 | 294 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | - | 0 | 0 | -0 | -0 | 0 | -0 | -0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -267 | -258 | -254 | -255 | -256 | -259 | -259 | -256 | -251 | -247 | -243 | -239 | ||||||
| Stockholders Equity | 40 | 49 | 51 | 50 | 49 | 44 | 43 | 46 | 45 | 48 | 51 | 55 | ||||||
| Liabilities And Stockholders Equity | 80 | 78 | 94 | 106 | 103 | 96 | 94 | 99 | 96 | 94 | 93 | 92 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts And Financing Receivable Allowance For Credit Loss | 2 | 2 | 2 | 2 | 2 | 2 | 1 | - | - | - | 1 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 140 | 140 | 140 | 140 | 139 | 139 | 139 | 139 | 130 | 130 | 130 | 130 | ||||||
| Shares Outstanding | 140 | 140 | 140 | 140 | 139 | 139 | 139 | 139 | 130 | 130 | 130 | 130 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialXtant Medical Holdings, Inc. (XTNT) — SEC Financial Statements & Analysis
Xtant Medical Holdings, Inc. (XTNT) is a surgical & medical instruments & apparatus company, incorporated in DE. Xtant Medical Holdings, Inc. trades on NYSE as: XTNT. Xtant Medical Holdings, Inc. (XTNT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, Xtant Medical Holdings, Inc. carries a market cap of $58.91M, a P/E ratio of -5.29x, a P/B ratio of 1.47x, a P/S ratio of 0.54x, an enterprise value of $71.71M, and an EV/EBITDA multiple of -11.08x. On profitability, it posts a gross margin of 59.39%, an operating margin of -9.58%, a net margin of -10.17%, a Return on Equity (ROE) of -25.16%, a Return on Assets (ROA) of -12.16%, and a Return on Invested Capital (ROIC) of -15.73%. Per share, it reports EPS of $-0.08, diluted EPS of $-0.08, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -14.28% year-over-year, net income growth of 143.17% year-over-year, and EPS growth of 141.52% year-over-year. On the balance sheet, it maintains a current ratio of 2.16x, a quick ratio of 0.99x, working capital of $34.81M, a debt-to-equity ratio of 0.99x, a debt ratio of 0.5, an interest coverage ratio of -3.80x, free cash flow of $-696.00K (TTM), and net debt of $12.80M. Figures sourced from SEC EDGAR.
- Market Cap
- $58.91M
- P/E TTM
- -5.29x
- EPS TTM
- $-0.08
- P/B TTM
- 1.47x
- ROE TTM
- -25.16%
- ROA TTM
- -12.16%
- Debt To Equity
- 0.99x
- Free Cash Flow TTM
- $-696.00K
- Net Revenue TTM Growth 1Y
- -14.28%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Xtant Medical Holdings, Inc. in?
Xtant Medical Holdings, Inc. (XTNT) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does XTNT trade on?
Xtant Medical Holdings, Inc. (XTNT) trades on the NYSE.
Where is Xtant Medical Holdings, Inc. incorporated?
Xtant Medical Holdings, Inc. is incorporated in DE.
When was Xtant Medical Holdings, Inc. (XTNT)'s most recent SEC filing?
Xtant Medical Holdings, Inc. (XTNT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is XTNT's market cap?
Xtant Medical Holdings, Inc. (XTNT) has a market capitalization of $58.91M as of 2026-06-30.
What is XTNT's EPS (earnings per share)?
Xtant Medical Holdings, Inc. (XTNT)'s trailing twelve month EPS is $-0.08 as of 2026-06-30.
What is XTNT's ROE (return on equity)?
Xtant Medical Holdings, Inc. (XTNT)'s trailing twelve month Return on Equity (ROE) is -25.16% as of 2026-06-30.
What is XTNT's ROA (return on assets)?
Xtant Medical Holdings, Inc. (XTNT)'s trailing twelve month Return on Assets (ROA) is -12.16% as of 2026-06-30.
What is XTNT's ROIC (return on invested capital)?
Xtant Medical Holdings, Inc. (XTNT)'s trailing twelve month Return on Invested Capital (ROIC) is -15.73% as of 2026-06-30.
What is XTNT's EV/EBITDA?
Xtant Medical Holdings, Inc. (XTNT)'s trailing twelve month EV/EBITDA is -11.08x as of 2026-06-30.